Search by name:
A B C D E F G H I J K L M N O P R S T U V W X Y Z
Diabetes
  • Glucophage
    $0.27
    Glucophage is an oral diabetes medicine used to treat type 2 of diabetes.
  • Glucotrol
    $0.27
    Glucotrol is sulfonylurea class of drugs, a drug used to treat type 2 of diabetes.
  • Actos
    $0.39
    Actos (Pioglitazone) is used to control high blood sugar in type 2 diabetes (non-insulin-dependent diabetes ...
  • DDAVP
    $4.04
    Generic DDAVP is used to prevent or control the frequent urination and loss of water caused by diabetes ...
  • Glucophage SR
    $0.72
    Glucophage SR is an oral diabetes medicine used to treat type 2 of diabetes.
  • Prandin
    $0.84
    Prandin is used to stimulate insulin secretion from the pancreas in treatment of type 2 of diabetes mellitus.
  • Precose
    $0.86
    Acarbose slows the digestion of carbohydrates in the body, which helps control blood sugar levels.
  • Amaryl
    $0.64
    Amaryl is an oral blood sugar-lowering drug which belongs to the class of sulfonylureas.
  • Glucotrol Xl
    $0.31
    Glucotrol Xl is sulfonylurea class of drugs, a drug used to treat type 2 of diabetes.
  • Glucovance
    $0.71
    Glucovance is a combination of two orally taken drugs possessing a hyproglycemic effect. Used to treat ...
  • Glycomet
    $1.03
    Glycomet is an oral diabetes medicine used to treat type 2 of diabetes.
  • Micronase
    $0.44
    Micronase contains glyburide, which lowers glucose levels in the blood.
  • Starlix
    $0.78
    Starlix (nateglinide) is an oral diabetes medicine that helps control blood sugar levels.
Payment Methods
Secure Payment Process
News
Millions 'missing out' on NHS dentistry
Patients are being turned away, stuck on waiting lists and put off by cost, BBC analysis suggests.
More families come forward in Shropshire maternity inquiry
Campaigners say 25 new cases have emerged since the leak of a report into maternity care in Shropshire.
Old age: Why 70 may be the new 65
Experts say health and life expectancy gains mean it is time to rethink how we measure and define being elderly.